Last week’s Melbourne Community Update Meeting was a resounding success, bringing together over 50 community members for an inspiring evening of connection, learning, and shared purpose. The collaboration between FSHD Global Research Foundation and Muscular Dystrophy Australia once again demonstrated the strength of our united community.
The evening featured compelling presentations from an impressive lineup of speakers. Dr Ian Woodcock shared insights on clinical trial readiness and current trials in Australia and globally, while Dr Katy de Valle from RCH Melbourne presented updates on the paediatric natural history study and MOVE Peds research. Emma Weatherley discussed the ‘Cure FSHD’ platform and Project Mercury, and Declan Carmichael from Springbok Analytics introduced attendees to cutting-edge muscle imaging technology. Catherine Stace from MDA outlined their comprehensive services, programs, and support offerings for the community.
Beyond the informative presentations, the meeting served as a wonderful opportunity for community members to reconnect with familiar faces and welcome newcomers into the fold. Family members, carers, and friends joined together in an atmosphere of mutual support and shared determination.
The positive energy in the room was palpable as attendees engaged with researchers, asked thoughtful questions, and connected with one another over light refreshments. These gatherings remind us that while FSHD may be rare, our community is vibrant, engaged, and growing stronger together.
Events like this reinforce the importance of bringing people together to share knowledge, build connections, and stay informed about research developments. The enthusiasm and participation from all 50+ attendees made it clear that our Melbourne community remains deeply committed to advancing research and supporting one another on this journey.
We’re already looking forward to our next community gathering and the opportunity to continue building these meaningful connections while keeping everyone informed about the latest developments in FSHD research and treatment possibilities.
